The Food and Drug Administration has issued Emergency Use Authorization for Abbott’s AdviseDx SARS-CoV-2 IgM (immunoglobulin M) lab-based serology test for use on the Architect and Alinity platforms.
CHICAGO (NewsNation Now) — The U.S. Food and Drug Administration (FDA) issued an emergency use approval for Abbott’s latest lab-based COVID-19 IgM antibody test, the company announced Monday. Abbott ...
"Our new SARS-CoV-2 IgM assay provides information about an individual's immune status with a positive predictive value of 95.5% in a population with disease incidence as low as 3%," said Julie Sawyer ...
The current COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a betacoronavirus that causes severe acute respiratory distress in a significant proportion of ...
(RTTNews) - Abbott (ABT) announced the FDA has issued Emergency Use Authorization for the company's AdviseDx SARS-CoV-2 IgM (Immunoglobulin M) lab-based serology test for use on the ARCHITECT and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results